Our resources

Regulatory submissions

A Study to Test the Effect of Survodutide on Cardiovascular Safety in People With Overweight or Obesity (2023)
FDA
A Study to Test the Effect of Survodutide on Cardiovascular Safety in People With Overweight or Obesity (2023)
READ MORE →
 Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy (2013)
FDA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy (2013)
READ MORE →
 Canakinumab in Patients With COVID-19 and Type 2 Diabetes (2020)
Academic Trials
Canakinumab in Patients With COVID-19 and Type 2 Diabetes (2020)
READ MORE →
 Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (2021)
FDA
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (2021)
READ MORE →
 Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (2019)
FDA
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (2019)
READ MORE →
 Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (2019)
FDA
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (2019)
READ MORE →
 SHAPERS: Efficacy and safety of short-course radiotherapy (SCRT) versus total neoadjuvant therapy in older patients with locally advanced rectal cancer (2021)
Academic Trials
SHAPERS: Efficacy and safety of short-course radiotherapy (SCRT) versus total neoadjuvant therapy in older patients with locally advanced rectal cancer (2021)
READ MORE →
 Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (2023)
FDA
Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (2023)
READ MORE →
 CardiAMP™ Cell Therapy for Heart Failure Trial (2016)
FDA
CardiAMP™ Cell Therapy for Heart Failure Trial (2016)
READ MORE →
 Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (2019)
FDA
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (2019)
READ MORE →
 Metoprolol in Acute Respiratory Distress Syndrome (2023)
Academic Trials
Metoprolol in Acute Respiratory Distress Syndrome (2023)
READ MORE →
 A Study of Retatrutide in Participants Who Have Obesity or Overweight (2023)
FDA
A Study of Retatrutide in Participants Who Have Obesity or Overweight (2023)
READ MORE →